Indivior Pharmaceuticals (INDV) Invested Capital (2021 - 2025)
Historic Invested Capital for Indivior Pharmaceuticals (INDV) over the last 5 years, with Q3 2025 value amounting to -$189.0 million.
- Indivior Pharmaceuticals' Invested Capital changed N/A to -$189.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$189.0 million, marking a year-over-year change of. This contributed to the annual value of -$4.0 million for FY2024, which is 10714.29% down from last year.
- Per Indivior Pharmaceuticals' latest filing, its Invested Capital stood at -$189.0 million for Q3 2025.
- Indivior Pharmaceuticals' Invested Capital's 5-year high stood at $375.0 million during Q4 2022, with a 5-year trough of -$267.0 million in Q1 2025.
- Its 5-year average for Invested Capital is $19.4 million, with a median of $10.0 million in 2024.
- In the last 5 years, Indivior Pharmaceuticals' Invested Capital soared by 1867.09% in 2022 and then plummeted by 277000.0% in 2025.
- Quarter analysis of 5 years shows Indivior Pharmaceuticals' Invested Capital stood at $316.0 million in 2021, then increased by 18.67% to $375.0 million in 2022, then plummeted by 85.07% to $56.0 million in 2023, then plummeted by 107.14% to -$4.0 million in 2024, then crashed by 4625.0% to -$189.0 million in 2025.
- Its Invested Capital was -$189.0 million in Q3 2025, compared to -$239.0 million in Q2 2025 and -$267.0 million in Q1 2025.